ADXN
Addex Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.55 / 10
Outperform
Fund flow analysis shows a good score (6.55/10) with block and extra-large inflows slightly offsetting smaller outflows, hinting at institutional interest despite negative overall trends. No analyst coverage is available, so sentiment is primarily derived from fund movements.
Fund Flow Rating
Is money flowing into or out of ADXN?
- ADXN holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.55/10 (Outperform).
